IT8648228A0 - Impiego di l-carnitina nel trattamento degli effetti tossici indotti dall'inalazione di alotano e di altri anestetici generali alogenati - Google Patents

Impiego di l-carnitina nel trattamento degli effetti tossici indotti dall'inalazione di alotano e di altri anestetici generali alogenati

Info

Publication number
IT8648228A0
IT8648228A0 IT8648228A IT4822886A IT8648228A0 IT 8648228 A0 IT8648228 A0 IT 8648228A0 IT 8648228 A IT8648228 A IT 8648228A IT 4822886 A IT4822886 A IT 4822886A IT 8648228 A0 IT8648228 A0 IT 8648228A0
Authority
IT
Italy
Prior art keywords
halothane
carnitine
inhalation
treatment
toxic effects
Prior art date
Application number
IT8648228A
Other languages
English (en)
Other versions
IT1195852B (it
IT8648228A1 (it
Inventor
Siliprandi Noris
Scutari Guido
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Priority to IT48228/86A priority Critical patent/IT1195852B/it
Publication of IT8648228A0 publication Critical patent/IT8648228A0/it
Priority to EP87830246A priority patent/EP0253777B1/en
Priority to DE8787830246T priority patent/DE3777270D1/de
Priority to ES198787830246T priority patent/ES2033341T3/es
Priority to AT87830246T priority patent/ATE73326T1/de
Priority to US07/069,256 priority patent/US4780308A/en
Publication of IT8648228A1 publication Critical patent/IT8648228A1/it
Application granted granted Critical
Publication of IT1195852B publication Critical patent/IT1195852B/it
Priority to GR920400692T priority patent/GR3004333T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IT48228/86A 1986-07-04 1986-07-04 Impiego di l-carnitina nel trattamento degli effetti tossici indotti dall'inalazione di alotano e di altri anestitici generali alogenati IT1195852B (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IT48228/86A IT1195852B (it) 1986-07-04 1986-07-04 Impiego di l-carnitina nel trattamento degli effetti tossici indotti dall'inalazione di alotano e di altri anestitici generali alogenati
EP87830246A EP0253777B1 (en) 1986-07-04 1987-07-01 Use of L-carnitine for the manufacture of a medicament for the treatment of toxic effects induced by the inhalation of halothane and other halogen-containing general anesthetics.
DE8787830246T DE3777270D1 (de) 1986-07-04 1987-07-01 Verwendung von l-carnitin zur herstellung eines arzneimittels zur behandlung von toxischen effekten, induziert durch die inhalation von halotan und anderen halogen enthaltenden allgemeinen anaesthetika.
ES198787830246T ES2033341T3 (es) 1986-07-04 1987-07-01 Uso de la l-carnitina en el tratamiento de los efectos toxicos inducidos por inhalacion de halotane y otros anestesicos generales conteniendo halogenos.
AT87830246T ATE73326T1 (de) 1986-07-04 1987-07-01 Verwendung von l-carnitin zur herstellung eines arzneimittels zur behandlung von toxischen effekten, induziert durch die inhalation von halotan und anderen halogen enthaltenden allgemeinen anaesthetika.
US07/069,256 US4780308A (en) 1986-07-04 1987-07-02 Use of L-carnitine in the treatment of toxic effects induced by the inhalation of halotane and other halogen-containing general anesthetics
GR920400692T GR3004333T3 (it) 1986-07-04 1992-04-13

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48228/86A IT1195852B (it) 1986-07-04 1986-07-04 Impiego di l-carnitina nel trattamento degli effetti tossici indotti dall'inalazione di alotano e di altri anestitici generali alogenati

Publications (3)

Publication Number Publication Date
IT8648228A0 true IT8648228A0 (it) 1986-07-04
IT8648228A1 IT8648228A1 (it) 1988-01-04
IT1195852B IT1195852B (it) 1988-10-27

Family

ID=11265360

Family Applications (1)

Application Number Title Priority Date Filing Date
IT48228/86A IT1195852B (it) 1986-07-04 1986-07-04 Impiego di l-carnitina nel trattamento degli effetti tossici indotti dall'inalazione di alotano e di altri anestitici generali alogenati

Country Status (7)

Country Link
US (1) US4780308A (it)
EP (1) EP0253777B1 (it)
AT (1) ATE73326T1 (it)
DE (1) DE3777270D1 (it)
ES (1) ES2033341T3 (it)
GR (1) GR3004333T3 (it)
IT (1) IT1195852B (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1277147B1 (it) * 1995-01-20 1997-11-04 Sigma Tau Ind Farmaceuti Uso della carnitina e i suoi derivati per ridurre gli effetti tossici della ciclosporina-a e di altri farmaci immunosoppressivi.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346107A (en) * 1979-02-12 1982-08-24 Claudio Cavazza Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism

Also Published As

Publication number Publication date
EP0253777A2 (en) 1988-01-20
EP0253777B1 (en) 1992-03-11
GR3004333T3 (it) 1993-03-31
ES2033341T3 (es) 1993-03-16
IT1195852B (it) 1988-10-27
EP0253777A3 (en) 1990-01-31
US4780308A (en) 1988-10-25
ATE73326T1 (de) 1992-03-15
IT8648228A1 (it) 1988-01-04
DE3777270D1 (de) 1992-04-16

Similar Documents

Publication Publication Date Title
FI94028B (fi) Laite nenäsairauksien diagnoosia ja hoitoa varten
FI925673A7 (fi) 5,10,15,20-tetrakis(r-karboksifenyyli)porfiinin käyttö keuhkosyövän os oittamiseksi ja hoitamiseksi
FI933946A7 (fi) Hypoglykeemisinä aineina ja Alzheimerin taudin hoidossa käyttökelpoisia yhdisteitä
DE69721766D1 (de) Neue arzneiformulierung
IT9022471A0 (it) Procedimento e apparecchiatura per l'abbinamento univoco di farmaci corrispondenti a una terapia pescritta a un determinato paziente
CY2007001I2 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
EE03025B1 (et) Immunomoduleeriva toimega N,N'-diatsetüültsüstiini orgaanilised soolad, nende valmistamine ja kasutamine
TR26214A (tr) Baryum veya stronsiyum sulfid'in lavgalanma artiklarinin hazirlanmasi.
KR900007411A (ko) Nb-818의 용이흡수성 약제
FR2513126B1 (fr) Formulations pharmaceutiques comprenant de l'insuline humaine et du c-peptide humain
DE58903659D1 (de) Pharmazeutische zubereitung zur behandlung entzuendeter nasenschleimhaeute.
PL311031A1 (en) Use of concentrates comprising vwf in complex therapy in case of treatment by using anticoagulants and fibrinolitic drugs
NO914779D0 (no) Adenosin-forbindelse i ny krystallform, fremgangsmaate fordens fremstilling og terapeutisk anvendelse derav
SE8904189D0 (sv) Anordning foer straeckbehandling av en maenniskas rygg
ATE72397T1 (de) Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.
LV5819A4 (lv) (-)-benzhidrilsulfinilacetamids ta iegusanas panemiens un ta izmantosana terapija
IT1243994B (it) Dispositivo per la preparazione estemporanea e l'erogazione di soluzioni
IT9067177A0 (it) Mezzi per il trattamento terapeutico dell'apnea durante il sonno
BR8700230A (pt) Respirador eletronico infantil
LV5179A3 (lv) Preparats "etoksidins" teju kunga un zarnu slimibu profilaksei un arstesanai
IT207738Z2 (it) Benda premifistola per la praticita' e sicurezza di fine dialisi
KR860009194U (ko) 농사용 허리 보조기
BR7102796U (pt) Dispositivo protetor da conexao do scalp ao corpo do paciente
IT8847847A0 (it) Dispositivo per l'erogazione di ossigeno terapeutico composto e balsamico
GB9017658D0 (en) Inhaler for social and medical use

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970609